| Transplant & Heart Failure: 50 Years of Transplantation, What are Best Practices? | |
|---|---|
| 10:00 10:20 | Management of the Sensitized Pre- and Post-Transplant Patient Steve Webber, US |
| 10:20 10:40 | Surveillance Biopsies do we still need them? Francesco Parisi, Italy |
| 10:40 11:00 | Management of Coronary Artery Vasculopathy State of the Art Elfriede Pahl, US |
| 11:00 11:20 | Listing for Re-Transplantation: Indications and Outcomes Anne Dipchand, Canada |
| 11:20 11:40 | When a Heart Transplant isnt enough
. when are a Kidney or Liver Needed? Jonathan Johnson, US |
| 11:40 12:00 | Discussion |
| Transplant & Heart Failure: Bridging Together: Ventricular Assist Device (VAD) & ICU: Controversies | |
|---|---|
| 13:30 13:50 | VADs in Challenging Patients: Approaching the Tough Cases Eugen Sandica, Germany |
| 13:50 14:10 | Making it Work: VADs in Patients with Univentricular Physiology David Morales, US |
| 14:10 14:30 | Sweating the Details: How to Select the Patient to be Weaned? Jennifer Conway, Canada |
| 14:30 14:50 | Management of Common VAD Complications in the ICU Christina Vander Pluyme, US |
| 14:50 15:10 | Chronic VAD Therapy in Children Antonio Amodeo, Italy |
| 15:10 15:30 | Whats Next: The Future of VAD Therapy in Children Charles Fraser, US |
| Transplant & Heart Failure: Pushing the Limits in Pediatric Heart Transplantation | |
|---|---|
| 10:00 10:20 | Transplant after Cancer and Chemotherapy: How Long do we Have to Wait? Shigetoyo Kogaki, Japan |
| 10:20 10:40 | Transplant in Patients with Difficult Anatomy Including Single Lung Linda Addonizio, US |
| 10:40 11:00 | Elevated Pulmonary Vascular Resistance what can VADs do for you? Christian Pizarro, US |
| 11:00 11:20 | Transplant in Patients with Genetic Syndromes and Autism Elizabeth Blume, US |
| 11:20 11:40 | How Many Transplants do you get? 3rd, 4th, or More? Massimo Griselli, France/Saudi Arabia |
| 11:40 12:00 | Discussion |
| 10:00 - 10:10 | O1500 - Global Burden of Congenital Heart Disease Meghan Zimmerman, US |
|---|---|
| 10:10 - 10:20 | O1227 - The Humanitarian Footprint. Contributions of Global Pediatric Cardiac Surgery to the Human Development Index of Low and Middle Income Countries Marcelo Cardarelli, US |
| 10:20 - 10:30 | O1739 - Humanitarian Model to Rescue the Invisible Child: Free Cardiac Care for Congenital Heart Disease in India Ashish Katewa, India |
| 10:30 - 10:40 | O2273 - Successful Model of a Sustainable Program for Low Income Pediatric Children with Congenital Heart Diseases in Developing Countries Néstor Fernando Sandoval Reyes, Colombia |
| 10:40 - 10:50 | O2299 - Performance of Pediatric Cardiac Surgery Centers: a National Effort to reduce the gaps of burden of
congenital heart disease in Colombia Néstor Fernando Sandoval Reyes, Colombia |
| 10:50 - 11:00 | Discussion |
| Transplant/HF: The Best of Heart Failure and Transplant Hot Topics and Abstracts | |
|---|---|
| 10:00 - 10:10 | O2336 - Neonatal Ebsteins Anomaly Whats to Expect? Livia Kapusta, The Netherlands |
| 10:10 - 10:20 | O2823 - Heart Rate Reduction Strategy in Duchennes Muscular Dystrophy Rachele Adorisio, Vatican City |
| 10:20 - 10:30 | O2391 - Short-Term Prognostic Indicators in ACHD Patients with Heart Failure S. Lucy Roche, Canada |
| 10:30 - 10:40 | O1921 - Altered Aortic Valve Leaflet Gene Expression Following Continuous Flow VAD Therapy in Pediatric Patients Katsuhide Maeda, US |
| 10:40 - 10:50 | O1628 - Continuing Challenges in Pediatric MCS: Analysis of the Pedimacs Registry Elizabeth Blume, US |
| 10:50 - 11:00 | O1978 - Cardiac Regenerative Therapy Using Cardiac Progenitor Cell for Hypoplastic Left Heart Syndrome Shunji Sano, US |
| 11:00 11:20 | Pediatric Myocarditis an update Joseph Rossano, US |
| 11:20 11:40 | Medical Management of Childhood Hypertrophic Cardiomyopathy Juan Pablo Kaski, UK |
| 11:40 12:00 | ABO-Incompatible Transplantation Lessons Learned and Future Directions Lori West, Canada |
| Transplant & Heart Failure: Molecular and Genetic Basis of Heart Failure | |
|---|---|
| 13:30 13:50 | Pediatric Cardiomyopathy the Importance of Genetic and Metabolic Evaluation Matthew Fenton, UK |
| 13:50 14:10 | Proteomics of Heart Failure Anne Murphy, US |
| 14:10 14:30 | Mitochondria and Heart Failure Gary Lopaschuk, Canada |
| 14:30 14:50 | Biomarkers in Pediatric Heart Failure When and How to Use Them Daphne Hsu, US |
| 14:50 15:10 | Clinical Diagnosis in the Genome Era Challenges and New Horizons Seema Mital, Canada |
| 15:10 15:30 | Discussion |